Hercules Capital Inc - HTGC STOCK NEWS

Hercules Capital (NYSE: HTGC), the largest specialty financing provider to innovative venture, growth, and established stage companies, has announced its participation in an upcoming financial community event. The company's executive management team will be attending the KBW 2024 BDC Midtown March in New York, NY on Wednesday, October 2, 2024.

Hercules Capital, backed by leading venture capital and select private equity firms, offers financing solutions to companies at various stages of development. Interested parties can arrange meetings with Hercules management through KBW.

Arcus Biosciences (NYSE:RCUS) has secured a $250 million term loan facility from Hercules Capital, enhancing its financial position and operational flexibility. The facility includes $150 million committed, with $50 million drawn at closing and $100 million available at Arcus's discretion. This non-dilutive funding will support the recently announced Phase 3 PEAK-1 study for casdatifan, Arcus's HIF-2a inhibitor for clear cell renal cell carcinoma (ccRCC). The loan matures in five years, extendable to six, with an interest-only period of four years, extendable to five based on regulatory milestones. This financial boost allows Arcus to accelerate its development program for casdatifan across multiple ccRCC settings.

Hercules Capital (NYSE: HTGC) has received a BBB+ investment grade corporate rating reaffirmation from Kroll Bond Rating Agency (KBRA). This rating underscores Hercules' strong 20-year operating record and validates its differentiated business model in specialty financing for innovative venture, growth, and established stage companies.

The BBB+ rating reflects Hercules' diversified investment portfolio, focusing on senior secured first lien venture debt investments in technology and life sciences sectors. It also highlights the company's solid credit quality, robust risk management, and experienced investment team. KBRA's affirmation is supported by Hercules' proven access to capital markets, diversified funding mix, and high proportion of unsecured debt, providing solid protection for noteholders.

Hercules Capital (NYSE: HTGC) reported strong financial results for Q2 2024. The company achieved record total investment income of $125.0 million, up 7.5% year-over-year, and net investment income (NII) of $82.4 million, or $0.51 per share, an 8.8% increase year-over-year. Q2 saw total gross debt and equity commitments of $686.5 million and record gross fundings of $461.5 million, up 28.7% year-over-year. Hercules maintained a conservative balance sheet with net GAAP leverage of 93.3% and net regulatory leverage of 83.9%. The company's assets under management grew to approximately $4.6 billion, a 14.7% increase year-over-year. Hercules also reported an undistributed earnings spillover of $145.0 million, or $0.89 per ending shares outstanding.

Thumbtack, a technology company in the home services industry, has secured $75 million in financing from Silicon Valley Bank and Hercules Capital, Inc. (NYSE: HTGC). This comes after Thumbtack's best fiscal year, surpassing $300 million in revenue and achieving EBITDA profitability in 2023. The company's home segment revenue increased 30% year-over-year, with gross profit margins exceeding 90%.

Thumbtack recently launched its biggest product update, introducing 30 new features in its app. The update provides personalized recommendations for home projects and enables instant booking across over 100 categories. This financing aims to strengthen Thumbtack's position as it works to bring the $600 billion home services industry online, which is currently less than 10% digitized.

Hercules Capital (NYSE: HTGC) has declared a total cash distribution of $0.48 per share for the second quarter of 2024. This distribution comprises a $0.40 per share base distribution and an $0.08 per share supplemental distribution. The record date is set for August 13, 2024, with the payment date on August 20, 2024.

Hercules maintains a variable distribution policy, aiming to distribute 90% to 100% of its taxable quarterly income. The Board may also pay additional supplemental distributions to distribute approximately all annual taxable income in the year earned. For the quarter ended June 30, 2024, 100% of the distributions were derived from current and accumulated earnings and profits. Additionally, 80.74% of the distributions qualify as Qualified Interest Income (QII), which may be exempt from U.S. withholding tax on foreign accounts.

Hercules Capital (NYSE: HTGC), the largest specialty financing provider for innovative venture, growth, and established stage companies, has announced its second quarter 2024 financial results conference call. The call is scheduled for Thursday, August 1, 2024, at 2:00 p.m. PT (5:00 p.m. ET), with financial results to be released after market close on the same day.

Participants can register for telephone access, and a live webcast will be available on the investor relations section of the company's website at investor.htgc.com. An archived webcast replay will be accessible for at least 30 days following the conference call.

Pindrop, a leader in voice authentication and security, has secured $100 million in debt financing from Hercules Capital, Inc. (NYSE: HTGC). This funding will accelerate the development of Pindrop's audio, voice, and AI technologies to combat rising cyber threats, particularly in contact centers where fraud has increased by 60% in the last two years.

Pindrop's technologies have already analyzed 5.3 billion calls, prevented $2 billion in fraud losses, and detected 104 million spoof calls. The company recently launched Pindrop® Pulse, an audio deepfake detection solution, and released its 2024 Voice Intelligence and Security Report. Pindrop's CEO has participated in various government forums on AI and cybersecurity, highlighting the company's role in addressing emerging threats like deepfakes in elections and financial services.

Hercules Capital (NYSE: HTGC) has received approval from the U.S. Small Business Administration (SBA) for its fourth Small Business Investment Company (SBIC) license. This approval grants Hercules access to an additional $175.0 million in long-term debentures, increasing its total borrowing capacity through the SBIC program to $350.0 million.

The SBIC program has been a important component of Hercules' funding strategy since 2006. This new license will enable the company to continue supporting innovative technology and life sciences companies seeking growth capital while maintaining a diversified balance sheet and favorable cost of capital. Hercules has also received exemptive relief from the SEC, allowing it to exclude SBIC leverage from applicable asset coverage limits.